Tandem Diabetes Care, Inc. (TNDM)
NASDAQ • Healthcare
Last close at October 13, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Tandem Diabetes Care, Inc. currently loses $8.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 22 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Tandem Diabetes Care beat EPS expectations while revenue came in line with consensus, as sales in the second fiscal quarter of 2026 rose 5.8% to roughly $254.6 million (up from about $240.7 million a year ago), results it reported August 6, 2026. EPS of -$0.31 topped the -$0.32 estimate by $0.01, while revenue of $254.6 million was in line with the $255.0 million estimate (-0.2%). Gross profit was about $144.8 million and gross margin printed at roughly 57%, alongside an operating loss of about $13.8 million that translated to an operating margin of -5.4%. Net loss narrowed to roughly $21.2 million, down 59.6% from a net loss of about $52.4 million a year ago. The quarter also included negative operating cash flow of roughly $34.6 million. For the next period, consensus calls for EPS of -$0.26 on revenue of $266.1 million.
Next report — what to expect
Tandem Diabetes Care, Inc. (TNDM) reports on November 5, 2026. Wall Street expects EPS of -$0.247 on revenue of $265.9 million. For trailing context, revenue grew +5.8% year over year last quarter. TNDM has beaten EPS in 5 of 8 most recent quarters, a key point to watch versus consensus.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. develops insulin-delivery technology and related diabetes-management software in the medical device business. Listed on the NASDAQ as TNDM, the company sells its products globally and generated $1.0 billion of revenue in FY2025, with that business spanning connected pump hardware and software for diabetes care.
Today's Snapshot
TNDM closed 1.2% higher at 16.65.
Trading Volume
Below 10d avg (2.0M)
1.7M
vs S&P 500 Today
Outperforming Market
+1.24%
Updated: October 14, 2026 at 12:29 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$16.34 - $18.95Sell
- RSI (14)45.31Neutral
- Stochastic %K (14, 3, 3)56.42Neutral
- MACD Level (12, 26)-0.69Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.